(SLVM) Sylvamo - Overview
Sector: Basic Materials | Industry: Paper & Paper Products | Exchange: NYSE (USA) | Market Cap: 1.560m USD | Total Return: -24.2% in 12m
Avg Turnover: 14.8M
EPS Trend: -76.1%
Qual. Beats: -2
Rev. Trend: -82.8%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Sylvamo Corporation (NYSE: SLVM) is a global producer of uncoated freesheet (UFS), operating integrated and non-integrated mills across North America, Europe, and Latin America. The company manufactures a broad portfolio of paper products for office, digital, and commercial printing applications under established brands such as Hammermill, Chamex, and REY. Its business model relies on a diverse distribution network encompassing retail, e-commerce, and merchant channels to reach end users and converters.
The uncoated freesheet sector is characterized by high capital intensity and a reliance on vertical integration with pulp production to mitigate raw material price volatility. As a spin-off from International Paper, Sylvamo maintains significant market share in the cutsize paper segment, which remains a core component of global office infrastructure despite the long-term shift toward digital documentation. For a deeper look into the companys valuation metrics, consider reviewing the data on ValueRay.
Headquartered in Memphis, Tennessee, the company manages regional production hubs that allow it to serve local markets with reduced logistics costs. This geographic diversification helps hedge against regional economic fluctuations and varying demand cycles in the commercial printing and paper converting industries.
- Uncoated freesheet demand trends in North American and European office markets
- Input cost volatility for hardwood pulp and energy impacts operating margins
- Low-cost Brazilian production assets provide competitive advantage in global export markets
- Strategic capital allocation focusing on debt reduction and shareholder dividend returns
- Pricing power within the global brand portfolio offsets secular paper volume declines
| Net Income: 102.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -9.38 > 1.0 |
| NWC/Revenue: 10.32% < 20% (prev 10.71%; Δ -0.39% < -1%) |
| CFO/TA 0.08 > 3% & CFO 235.0m > Net Income 102.0m |
| Net Debt (851.0m) to EBITDA (381.0m): 2.23 < 3 |
| Current Ratio: 1.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (40.0m) vs 12m ago -2.44% < -2% |
| Gross Margin: 19.76% > 18% (prev 23.58%; Δ -3.83% > 0.5%) |
| Asset Turnover: 120.3% > 50% (prev 140.3%; Δ -20.06% > 0%) |
| Interest Coverage Ratio: 4.79 > 6 (EBIT TTM 201.0m / Interest Expense TTM 42.0m) |
| A: 0.12 (Total Current Assets 1.10b - Total Current Liabilities 758.0m) / Total Assets 2.83b |
| B: 0.88 (Retained Earnings 2.49b / Total Assets 2.83b) |
| C: 0.07 (EBIT TTM 201.0m / Avg Total Assets 2.73b) |
| D: 0.53 (Book Value of Equity 979.0m / Total Liabilities 1.85b) |
| Altman-Z'' = 4.70 = AA |
| DSRI: 1.01 (Receivables 398.0m/442.0m, Revenue 3.29b/3.69b) |
| GMI: 1.19 (GM 23.58% / 19.76%) |
| AQI: 0.37 (AQ_t 0.08 / AQ_t-1 0.22) |
| SGI: 0.89 (Revenue 3.29b / 3.69b) |
| TATA: -0.05 (NI 102.0m - CFO 235.0m) / TA 2.83b) |
| Beneish M = -3.30 (Cap -4..+1) = AA |
As of June 05, 2026, the stock is trading at USD 38.71 with a total of 384,038 shares traded.
Over the past week, the price has changed by -1.80%,
over one month by -8.14%,
over three months by -16.03% and
over the past year by -24.22%.
Sylvamo has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold SLVM.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 59 | 52.4% |
P/E Trailing = 15.6454
P/E Forward = 16.5563
P/S = 0.4785
P/B = 1.5862
Revenue TTM = 3.29b USD
EBIT TTM = 201.0m USD
EBITDA TTM = 381.0m USD
Long Term Debt = 766.0m USD (from longTermDebt, last quarter)
Short Term Debt = 174.0m USD (from shortTermDebt, last quarter)
Debt = 981.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 851.0m USD (calculated: Debt 981.0m - CCE 130.0m)
Enterprise Value = 2.41b USD (1.56b + Debt 981.0m - CCE 130.0m)
Interest Coverage Ratio = 4.79 (Ebit TTM 201.0m / Interest Expense TTM 42.0m)
EV/FCF = 241.1x (Enterprise Value 2.41b / FCF TTM 10.0m)
FCF Yield = 0.41% (FCF TTM 10.0m / Enterprise Value 2.41b)
FCF Margin = 0.30% (FCF TTM 10.0m / Revenue TTM 3.29b)
Net Margin = 3.11% (Net Income TTM 102.0m / Revenue TTM 3.29b)
Gross Margin = 19.76% ((Revenue TTM 3.29b - Cost of Revenue TTM 2.64b) / Revenue TTM)
Gross Margin QoQ = 11.13% (prev 26.29%)
Tobins Q-Ratio = 0.85 (Enterprise Value 2.41b / Total Assets 2.83b)
Interest Expense / Debt = 4.28% (Interest Expense 42.0m / Debt 981.0m)
Taxrate = 36.25% (58.0m / 160.0m)
NOPAT = 128.1m (EBIT 201.0m * (1 - 36.25%))
Current Ratio = 1.45 (Total Current Assets 1.10b / Total Current Liabilities 758.0m)
Debt / Equity = 1.00 (Debt 981.0m / totalStockholderEquity, last quarter 979.0m)
Debt / EBITDA = 2.23 (Net Debt 851.0m / EBITDA 381.0m)
Debt / FCF = 85.10 (Net Debt 851.0m / FCF TTM 10.0m)
Total Stockholder Equity = 970.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.73% (Net Income 102.0m / Total Assets 2.83b)
RoE = 10.51% (Net Income TTM 102.0m / Total Stockholder Equity 970.2m)
RoCE = 11.58% (EBIT 201.0m / Capital Employed (Equity 970.2m + L.T.Debt 766.0m))
RoIC = 6.04% (NOPAT 128.1m / Invested Capital 2.12b)
WACC = 6.90% (E(1.56b)/V(2.54b) * Re(9.52%) + D(981.0m)/V(2.54b) * Rd(4.28%) * (1-Tc(0.36)))
Discount Rate = 9.52% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -69.01 | Cagr: -2.15%
[DCF] Terminal Value 73.10% ; FCFF base≈108.4m ; Y1≈95.1m ; Y5≈76.8m
[DCF] Fair Price = 9.61 (EV 1.23b - Net Debt 851.0m = Equity 381.8m / Shares 39.7m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -76.11 | EPS CAGR: -28.12% | SUE: -1.27 | # QB: -2
Revenue Correlation: -82.83 | Revenue CAGR: -4.40% | SUE: 0.69 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.53 | Chg30d=-23.54% | Revisions=-43% | Analysts=3
EPS next Quarter (2026-09-30): EPS=1.58 | Chg30d=-0.47% | Revisions=+25% | Analysts=3
EPS current Year (2026-12-31): EPS=2.34 | Chg30d=-20.07% | Revisions=-50% | GrowthEPS=-33.9% | GrowthRev=+0.0%
EPS next Year (2027-12-31): EPS=5.58 | Chg30d=-5.20% | Revisions=-25% | GrowthEPS=+138.3% | GrowthRev=+3.7%
[Analyst] Revisions Ratio: -50%